Skip to Content
You are currently on the new version of our website. Access the old version .
ElectronicsElectronics
  • Article
  • Open Access

2 December 2022

19 Pages

Deep Learning for Predicting Congestive Heart Failure

,
,
and
1
LENS, European Laboratory for Nonlinear Spectroscopy, University of Florence, Via Nello Carrara 1, 50019 Firenze, Italy
2
Applied Biomedical Signal Processing and Intelligent eHealth (ABSPIE) Lab, School of Engineering, University of Warwick, Coventry CV4 7AL, UK
3
USL Toscana Centro, Department of Cardiology, Ospedale S. Maria Nuova, 50122 Florence, Italy
4
Department of Medical Biotechnologies, University of Siena, Via Aldo Moro, 2, 53100 Siena Tuscany, Italy

Abstract

Congestive heart failure (CHF) is one of the most debilitating cardiac disorders. It is a costly disease in terms of both lives and financial outlays, given the high rate of hospital re-admissions and mortality. Heart failure (HF) is notoriously difficult to identify on time, and is frequently accompanied by additional comorbidities that further complicate diagnosis. Many decision support systems (DSS) have been developed to facilitate diagnosis and to raise the standard of screening and monitoring operations, even for non-expert staff. This is confirmed in the literature by records of highly performing diagnosis-aid systems, which are unfortunately not very relevant to expert cardiologists. In order to assist cardiologists in predicting the trajectory of HF, we propose a deep learning-based system which predicts severity of disease progression by employing medical patient history. We tested the accuracy of four models on a labeled dataset, composed of 1037 records, to predict CHF severity and progression, achieving results comparable to studies based on much larger datasets, none of which used longitudinal multi-class prediction. The main contribution of this work is that it demonstrates that a fairly complicated approach can achieve good results on a medium size dataset, providing a reasonably accurate means of determining the evolution of CHF well in advance. This potentially constitutes a significant aid for healthcare managers and expert cardiologists in designing different therapies for medication, healthy lifestyle changes and quality of life (QoL) management, while also promoting allocation of resources with an evidence-based approach.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.